On January 1, 2011, Medicare’s prospective payment system for dialysis services (“bundling”) debuted. Dialysis centers now are paid a flat global fee for all the care provided to a patient.
Recent studies suggest that after the introduction of bundled payments, use of erythropoiesis-stimulating agents (ESAs) has decreased (although ESA labeling changes also are cited as a possible cause of decreased ESA use) and use of intravenous iron has increased.
Renal & Urology News would like to know what nephrologists’ experience has been since the debut of bundling, so please answer the following poll question.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.
